Press Releases
Biological E. Limited Acquires Akorn India
Biological E. Limited, a Hyderabad-based pharmaceuticals & Biologics company, announced the acquisition of Akorn India Limited, a subsidiary of Akorn Inc., USA.
By this strategic acquisition, BE, which manufactures specialty generic injectable medicines and also vaccines, will be able to...
Press Releases
Regeneron Announces FDA Accepts Evinacumab BLA for Priority Review as Treatment for Patients with HoFH
Regeneron Pharmaceuticals, Inc. announced that the U.S. FDA has accepted for Priority Review a Biologics License Application (BLA) for evinacumab as an adjunct to other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH). Evinacumab is the first investigational...
Press Releases
Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-1
Pfizer Inc. announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the...
Press Releases
Catalent Gene Therapy Facility Receives FDA Approval as an Additional Manufacturing Site for AveXis Gene Therapy
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it was approved by the U.S. FDA to produce commercial drug substance intermediate...
Press Releases
Alpha Capital LLC and OncoGenerix Announce New Pharmaceutical Factory in the US
Novel and generics pharma producer OncoGenerix and Alpha Capital LLC have come to an agreement to build a new injectable pharmaceutical factory in the US. The production facility will serve as an affiliate factory, similar to the one that...
Press Releases
U.S. Govt. Selects Grand River Aseptic Manufacturing to Help Combat COVID-19
Grand River Aseptic Manufacturing, a leading parenteral contract development and manufacturing organization (CDMO), has been selected by the U.S. Department of Health and Human Services and the U.S. Department of Defense to support the expansion of the United States’...
Press Releases
AGC Biologics, Novavax Expand Coronavirus Vax Pact
AGC Biologics, a global biopharmaceutical CDMO, announced it has expanded its partnership with Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases. AGC Biologics is currently preparing to manufacture Matrix-M™, the adjuvant component of Novavax’...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read